NO20015062D0 - Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser - Google Patents

Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser

Info

Publication number
NO20015062D0
NO20015062D0 NO20015062A NO20015062A NO20015062D0 NO 20015062 D0 NO20015062 D0 NO 20015062D0 NO 20015062 A NO20015062 A NO 20015062A NO 20015062 A NO20015062 A NO 20015062A NO 20015062 D0 NO20015062 D0 NO 20015062D0
Authority
NO
Norway
Prior art keywords
naphthyridine
cyano
inhibitors
substituted
tyrosine kinases
Prior art date
Application number
NO20015062A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015062L (no
Inventor
Allan Wissner
Philip Ross Hamann
Ayako Yamashita
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO20015062D0 publication Critical patent/NO20015062D0/no
Publication of NO20015062L publication Critical patent/NO20015062L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20015062A 1999-04-21 2001-10-18 Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser NO20015062L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29550799A 1999-04-21 1999-04-21
PCT/US2000/010250 WO2000066583A1 (en) 1999-04-21 2000-04-18 Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases

Publications (2)

Publication Number Publication Date
NO20015062D0 true NO20015062D0 (no) 2001-10-18
NO20015062L NO20015062L (no) 2001-10-18

Family

ID=23138006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015062A NO20015062L (no) 1999-04-21 2001-10-18 Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser

Country Status (23)

Country Link
EP (1) EP1171440B1 (es)
JP (1) JP2002543198A (es)
KR (1) KR20020002433A (es)
CN (1) CN100408576C (es)
AR (1) AR029880A1 (es)
AT (1) ATE264328T1 (es)
AU (1) AU776962B2 (es)
BR (1) BR0009870A (es)
CA (1) CA2365212A1 (es)
CZ (1) CZ20013660A3 (es)
DE (1) DE60009888T2 (es)
DK (1) DK1171440T3 (es)
ES (1) ES2216884T3 (es)
HK (1) HK1040077B (es)
HU (1) HUP0200816A3 (es)
IL (1) IL145870A0 (es)
NO (1) NO20015062L (es)
NZ (1) NZ514576A (es)
PL (1) PL350920A1 (es)
PT (1) PT1171440E (es)
RU (1) RU2001131356A (es)
WO (1) WO2000066583A1 (es)
ZA (1) ZA200108015B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2003002287A1 (es) * 2002-11-25 2005-01-14 Wyeth Corp COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
US7276519B2 (en) 2002-11-25 2007-10-02 Wyeth Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
MX2007014258A (es) * 2005-05-18 2008-01-22 Wyeth Corp Inhibidores de 4,6-diamino-[1,7]naftiridin-3-carbonitrilo de la tpl2 cinasa y metodos de fabricacion y uso de los mismos.
CN101415685B (zh) 2006-01-31 2011-08-24 阿雷生物药品公司 激酶抑制剂及其使用方法
ES2301380B1 (es) * 2006-08-09 2009-06-08 Laboratorios Almirall S.A. Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es) 2007-04-26 2010-09-23 Laboratorios Almirall S.A. Nuevos derivados de 4,8-difenilpoliazanaftaleno.
EP2108641A1 (en) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
SG176978A1 (en) 2009-06-25 2012-02-28 Amgen Inc Heterocyclic compounds and their uses
EP2332939A1 (en) 2009-11-26 2011-06-15 Æterna Zentaris GmbH Novel Naphthyridine derivatives and the use thereof as kinase inhibitors
CA2816957A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
CN102675311A (zh) * 2011-06-14 2012-09-19 苏春华 一种氟代丙烯酰胺的衍生物
KR20140117651A (ko) * 2012-01-30 2014-10-07 에프. 호프만-라 로슈 아게 이소퀴놀린 및 나프티리딘 유도체
UY35772A (es) 2013-10-14 2015-05-29 Bayer Cropscience Ag Nuevos compuestos plaguicidas
EP3401309A4 (en) * 2015-12-24 2019-11-27 Kyowa Kirin Co., Ltd. UNSATURATED AMIDE COMPOUND ALPHA, BETA
CN107556309B (zh) * 2017-09-11 2020-12-01 浙江永宁药业股份有限公司 多取代四氢萘啶类化合物的药物用途及其制备方法
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
CN1252054C (zh) * 1996-09-25 2006-04-19 曾尼卡有限公司 抑制生长因子的作用的喹啉衍生物
UA73073C2 (uk) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
TW436485B (en) * 1997-08-01 2001-05-28 American Cyanamid Co Substituted quinazoline derivatives

Also Published As

Publication number Publication date
PT1171440E (pt) 2004-07-30
EP1171440B1 (en) 2004-04-14
PL350920A1 (en) 2003-02-10
CZ20013660A3 (cs) 2002-01-16
RU2001131356A (ru) 2003-06-27
AR029880A1 (es) 2003-07-23
DE60009888T2 (de) 2005-04-21
KR20020002433A (ko) 2002-01-09
CN1347416A (zh) 2002-05-01
DK1171440T3 (da) 2004-08-02
JP2002543198A (ja) 2002-12-17
BR0009870A (pt) 2002-01-08
EP1171440A1 (en) 2002-01-16
HUP0200816A3 (en) 2003-06-30
NZ514576A (en) 2004-02-27
HUP0200816A2 (en) 2002-08-28
CA2365212A1 (en) 2000-11-09
AU4463900A (en) 2000-11-17
ZA200108015B (en) 2003-03-26
ES2216884T3 (es) 2004-11-01
WO2000066583A1 (en) 2000-11-09
AU776962B2 (en) 2004-09-30
CN100408576C (zh) 2008-08-06
HK1040077B (zh) 2004-09-10
ATE264328T1 (de) 2004-04-15
NO20015062L (no) 2001-10-18
DE60009888D1 (de) 2004-05-19
IL145870A0 (en) 2002-07-25
HK1040077A1 (en) 2002-05-24

Similar Documents

Publication Publication Date Title
HK1244797A1 (zh) 環蛋白酪氨酸激酶抑制劑
ZA200202985B (en) Tyrosine kinase inhibitors.
HUS1700048I1 (hu) Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai
EP1161433A4 (en) TYROSINE KINASE INHIBITORS
ZA200108291B (en) Diaminothiazoles and their use for inhibiting protein kinases.
ZA9810219B (en) Benzothiazole protein tyrosine kinase inhibitors.
HK1049154A1 (zh) 作為酪氨酸激酶抑制劑的2-吡唑啉-5-酮
NO20015062D0 (no) Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser
AU2437900A (en) Piperidinylquinolines as protein tyrosine kinase inhibitors
PL346934A1 (en) Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
HK1048813A1 (en) Indazole compounds and pharmaceutical compositionsfor inhibiting protein kinases, and methods for their use.
ZA200206386B (en) Kinase inhibitors.
MXPA03008690A (es) Inhibidores novedosos de tirosina cinasa.
DK1000039T3 (da) Substituerede quinazolinderivater og anvendelse deraf som tyrosinkinaseinhibitorer
EP1259236A4 (en) Tyrosine kinase inhibitors
ZA975380B (en) Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors.
ATE387448T1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
ZA200307306B (en) Indolines, substituted in portion 6, and their use as kinase inhibitors.
AU2576501A (en) Protein kinase inhibitors
ZA200110053B (en) Factor via inhibitors.
HK1048318A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors.
AU2876000A (en) Tyrosine kinase inhibitors and methods of using the same
MA25815A1 (fr) Derives de 4,5-dihydro-thiazol-2-ylamine et leur utilisation comme inhibiteurs de no synthase.
ZA200203157B (en) Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application